Literature DB >> 8232608

Action of cisapride on rat colonic secretion.

J C Bandi1, G Rosembeck, J A De Paula, M I Ledesma de Paolo, D Celener, P C Gravelle, L Bustos Fernandez.   

Abstract

The stimulating effect of cisapride on the motility of the digestive tract is well known. However, there are only a few studies on the influence of this drug on the absorptive or secretory activity of the colonic mucosa. In the present study, the ability of cisapride to alter the mural transport of water and electrolytes in the colon and its effects on mucus secretion and albumin permeation were studied. The effects of cisapride on the rat colon in vivo were studied under different conditions, by means of an instillation of sodium acetate solution at pH 6.9, which induced absorption of water and electrolytes, and in two models of colonic secretion, one employing the instillation of an acetic acid solution at pH 2.9 and the other, an intravenous infusion of 5-hydroxytryptamine (serotonin) 45 micrograms.kg-1.min-1 together with intracolonic instillation of sodium acetate. Cisapride (i.v.), at a dose of 0.32 mg.kg-1, in rats whose colon was instilled with sodium acetate (pH 6.9) induced an increase in sodium absorption and a reduction in water absorption. Cisapride (i.v.), at doses of 0.32, 0.64 and 1.0 mg.kg-1, inhibited the secretion of water, Na+, Cl-, and mucus and the permeation of albumin induced by acetic acid instillation or by serotonin infusion. It is concluded that the effect of cisapride on the colonic mucosa varies in accordance with the functional mucosal conditions and that this action may be of clinical importance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232608     DOI: 10.1007/bf00169162

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Organic anions induce colinic secretion.

Authors:  L Bustos-Fernández; E González; L L de Paolo; C D Celener; K O de Furuya
Journal:  Am J Dig Dis       Date:  1976-04

Review 2.  5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.

Authors:  B Costall; R J Naylor
Journal:  Scand J Gastroenterol       Date:  1990-08       Impact factor: 2.423

3.  The action of R51619 on transport processes in the rat small intestine.

Authors:  J Hardcastle; P T Hardcastle; D K Kelleher
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

4.  Identification of EC cells in the human intestine: a comparative study between immunohistochemical and silver impregnation techniques.

Authors:  H Inokuchi; K Kawai; Y Takeuchi; Y Sano
Journal:  Histochemistry       Date:  1983

5.  Immunohistochemical demonstration of EC cells in rat gastrointestinal tract.

Authors:  H Inokuchi; K Kawai; Y Takeuchi; Y Sano
Journal:  Histochemistry       Date:  1982

6.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

7.  Characterization of the muscarine receptors involved in the modulation of serotonin release from the vascularly perfused small intestine of guinea pig.

Authors:  H Schwörer; K Racké; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

8.  Inhibition of the effect of serotonin on rat ileal transport by cisapride: evidence in favour of the involvement of 5-HT2 receptors.

Authors:  K J Moriarty; N B Higgs; M Woodford; G Warhurst; L A Turnberg
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

9.  Serotonin-induced alteration of colonic electrolyte transport in the rat.

Authors:  T W Zimmerman; H J Binder
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

10.  Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum.

Authors:  H Schwörer; K Racké; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.